mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0061 |
0.9 |
mRNA |
SB-743921 |
CTRPv2 |
pan-cancer |
AAC |
-0.0062 |
0.9 |
mRNA |
CCT018159 |
GDSC1000 |
pan-cancer |
AAC |
-0.0062 |
0.9 |
mRNA |
AZD8055 |
GDSC1000 |
pan-cancer |
AAC |
0.006 |
0.9 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0097 |
0.9 |
mRNA |
GSK525762A |
CTRPv2 |
pan-cancer |
AAC |
0.0054 |
0.9 |
mRNA |
AP-24534 |
GDSC1000 |
pan-cancer |
AAC |
0.0058 |
0.9 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
-0.0051 |
0.9 |
mRNA |
AUY922 |
GDSC1000 |
pan-cancer |
AAC |
-0.0061 |
0.9 |
mRNA |
UNC0638 |
GDSC1000 |
pan-cancer |
AAC |
-0.0051 |
0.9 |